US4808608A
(en)
|
1986-01-23 |
1989-02-28 |
Merck & Co., Inc. |
Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
|
DE3631824A1
(de)
|
1986-02-21 |
1988-03-31 |
Bayer Ag |
Cycloalkano(1.2-b)indol-sulfonamide
|
GB8924392D0
(en)
|
1989-10-30 |
1989-12-20 |
Bayer Ag |
Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
|
WO2001078697A2
(en)
|
2000-04-12 |
2001-10-25 |
Merck Frosst Canada & Co. |
Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
JP4279561B2
(ja)
|
2001-05-23 |
2009-06-17 |
メルク フロスト カナダ リミテツド |
プロスタグランジンD2受容体拮抗薬としてのジヒドロピロロ[1,2−a]インドールおよびテトラヒドロピリド[1,2−a]−インドール誘導体
|
TWI246423B
(en)
|
2001-12-14 |
2006-01-01 |
Zentaris Gmbh |
Tetrahydrocarbazole derivatives as ligands for g-protein-coupled receptors (GPCR)
|
AR038136A1
(es)
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
|
SE0200356D0
(sv)
|
2002-02-05 |
2002-02-05 |
Astrazeneca Ab |
Novel use
|
SE0200411D0
(sv)
|
2002-02-05 |
2002-02-05 |
Astrazeneca Ab |
Novel use
|
AU2003231513A1
(en)
|
2002-05-16 |
2003-12-02 |
Shionogi And Co., Ltd. |
Pgd2 receptor antagonist
|
EP2423190A1
(en)
|
2002-05-16 |
2012-02-29 |
Shionogi&Co., Ltd. |
Compounds Exhibiting PGD 2 Receptor Antagonism
|
GB2388540A
(en)
|
2002-05-17 |
2003-11-19 |
Bayer Ag |
New use of Ramatroban
|
SE0201635D0
(sv)
|
2002-05-30 |
2002-05-30 |
Astrazeneca Ab |
Novel compounds
|
TW200307542A
(en)
|
2002-05-30 |
2003-12-16 |
Astrazeneca Ab |
Novel compounds
|
SE0202241D0
(sv)
|
2002-07-17 |
2002-07-17 |
Astrazeneca Ab |
Novel Compounds
|
KR20050084890A
(ko)
|
2002-10-30 |
2005-08-29 |
머크 프로스트 캐나다 앤드 캄파니 |
피리도피롤리진 및 피리도인돌리진 유도체
|
EP1600440A1
(en)
|
2003-03-06 |
2005-11-30 |
Ono Pharmaceutical Co., Ltd. |
Indole derivative compounds and drugs containing the compounds as the active ingredient
|
JP2006528938A
(ja)
|
2003-05-20 |
2006-12-28 |
メルク フロスト カナダ リミテツド |
フルオロ−メタンスルホニル置換シクロアルカノインドール、およびプロスタグランジンd2アンタゴニストとしてのこれらの使用
|
SE0301569D0
(sv)
|
2003-05-27 |
2003-05-27 |
Astrazeneca Ab |
Novel compounds
|
WO2004111047A2
(en)
|
2003-06-12 |
2004-12-23 |
Merck Frosst Canada Ltd. |
Cycloalkanepyrrolopyridines as dp receptor antagonists
|
SE0302232D0
(sv)
|
2003-08-18 |
2003-08-18 |
Astrazeneca Ab |
Novel Compounds
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
AU2004283139A1
(en)
|
2003-10-14 |
2005-05-06 |
Oxagen Limited |
Compounds having CRTH2 antagonist activity
|
WO2005040112A1
(en)
|
2003-10-14 |
2005-05-06 |
Oxagen Limited |
Compounds with pgd2 antagonist activity
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
GB2407318A
(en)
|
2003-10-23 |
2005-04-27 |
Oxagen Ltd |
Substituted Indol-3-yl acetic acid derivatives
|
SE0303180D0
(sv)
|
2003-11-26 |
2003-11-26 |
Astrazeneca Ab |
Novel compounds
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
JP4996257B2
(ja)
|
2004-01-31 |
2012-08-08 |
アクチミス ファーマシューティカルズ インコーポレーテッド |
イミダゾ[1,2−c]ピリミジニル酢酸誘導体
|
RU2376286C2
(ru)
|
2004-03-11 |
2009-12-20 |
Актелион Фармасьютиклз Лтд |
Производные индол-1-илуксусной кислоты
|
US7714132B2
(en)
|
2004-03-11 |
2010-05-11 |
Actelion Pharmaceuticals, Ltd. |
Tetrahydropyridoindole derivatives
|
US20050234030A1
(en)
|
2004-04-20 |
2005-10-20 |
Wilmin Bartolini |
Modulators of CRTH2, COX-2 and FAAH
|
GB0412914D0
(en)
|
2004-06-10 |
2004-07-14 |
Oxagen Ltd |
Compounds
|
MY144903A
(en)
|
2004-06-17 |
2011-11-30 |
Novartis Ag |
Pyrrolopyridine derivatives and their use as crth2 antagonists
|
KR20070089908A
(ko)
|
2004-09-21 |
2007-09-04 |
아더시스 인코포레이티드 |
Crth2 수용체 길항작용을 나타내는 인돌 아세트산 및이의 용도
|
KR20070115865A
(ko)
|
2004-09-21 |
2007-12-06 |
아더시스 인코포레이티드 |
Crth2 수용체 길항작용을 나타내는 벤즈이미다졸아세트산 및 이의 용도
|
GB0427381D0
(en)
|
2004-12-14 |
2005-01-19 |
Novartis Ag |
Organic compounds
|
PT1833791E
(pt)
|
2004-12-27 |
2011-10-19 |
Actelion Pharmaceuticals Ltd |
Derivados de 2,3,4,9-tetra-hidro-1h-carbazol como antgonistas do receptor crth2
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
GB2422830A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
GB2422829A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
GB2422831A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
ES2395929T3
(es)
|
2005-02-25 |
2013-02-18 |
Ono Pharmaceutical Co., Ltd. |
Compuestos de indol para tratar trastornos respiratorios
|
GB0504150D0
(en)
|
2005-03-01 |
2005-04-06 |
Oxagen Ltd |
Microcrystalline material
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
ZA200709819B
(en)
|
2005-05-24 |
2009-09-30 |
Serono Lab |
Tricyclic spiro derivatives as CRTH2 modulators
|
GB0512944D0
(en)
|
2005-06-24 |
2005-08-03 |
Argenta Discovery Ltd |
Indolizine compounds
|
JP5072594B2
(ja)
|
2005-07-22 |
2012-11-14 |
塩野義製薬株式会社 |
Pgd2受容体アンタゴニスト活性を有するインドール誘導体
|
US7842692B2
(en)
|
2005-07-22 |
2010-11-30 |
Shionogi & Co., Ltd. |
Azaindole derivative having PGD2 receptor antagonistic activity
|
US7696222B2
(en)
|
2005-08-12 |
2010-04-13 |
Merck Frosst Canada Ltd |
Indole derivatives as CRTH2 receptor antagonists
|
EP1931632A4
(en)
|
2005-08-18 |
2011-05-11 |
Microbia Inc |
USEFUL INDOOR CONNECTIONS
|
US8143285B2
(en)
|
2005-09-06 |
2012-03-27 |
Shionogi & Co., Ltd. |
Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
GB0521275D0
(en)
|
2005-10-19 |
2005-11-30 |
Argenta Discovery Ltd |
3-Aminoindole compounds
|
GB0525143D0
(en)
|
2005-12-09 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
GB0525141D0
(en)
|
2005-12-09 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
GB0525144D0
(en)
|
2005-12-09 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
GB0525337D0
(en)
|
2005-12-13 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
GB0605743D0
(en)
|
2006-03-22 |
2006-05-03 |
Oxagen Ltd |
Salts with CRTH2 antagonist activity
|
WO2007138282A2
(en)
|
2006-05-26 |
2007-12-06 |
Astrazeneca Ab |
Bi-aryl or aryl-heteroaryl substituted indoles
|
GB0611695D0
(en)
|
2006-06-13 |
2006-07-26 |
Novartis Ag |
Organic compounds
|
PL2046740T3
(pl)
|
2006-07-22 |
2012-10-31 |
Oxagen Ltd |
Związki o aktywności antagonisty CRTH2
|
CA2659055A1
(en)
|
2006-07-25 |
2008-01-31 |
Sanofi-Aventis |
2-phenyl-indoles as prostaglandin d2 receptor antagonists
|
ES2374321T3
(es)
|
2006-08-07 |
2012-02-15 |
Actelion Pharmaceuticals Ltd. |
Derivados del ácido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acético.
|
MX2009006762A
(es)
|
2006-12-21 |
2009-08-20 |
Argenta Discovery Ltd |
Antagonistas crth2.
|
GB0625842D0
(en)
|
2006-12-22 |
2007-02-07 |
Argenta Discovery Ltd |
Indolizine derivatives
|
EP2136804A1
(en)
|
2007-03-21 |
2009-12-30 |
Argenta Oral Therapeutics Limited |
Indolizine acetic acid derivatives as crth2 antagonists
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
GB0719485D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
BRPI0815948A2
(pt)
|
2007-10-10 |
2019-09-24 |
Chemietek Llc |
"compostos heterocíclicos como antagonistas de receptorncrth2"
|
WO2009061676A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
DK2327693T3
(da)
|
2007-12-14 |
2012-08-13 |
Pulmagen Therapeutics Asthma Ltd |
Indoler og terapeutisk anvendelse deraf
|
US7750027B2
(en)
|
2008-01-18 |
2010-07-06 |
Oxagen Limited |
Compounds having CRTH2 antagonist activity
|
EP2245010A1
(en)
|
2008-01-18 |
2010-11-03 |
Pulmagen Therapeutics (Asthma) Limited |
Indoles active on crth2 receptor
|
MY155133A
(en)
|
2008-01-18 |
2015-09-15 |
Atopix Therapeutics Ltd |
Compounds having crth2 antagonist activity
|
JP2011509990A
(ja)
|
2008-01-22 |
2011-03-31 |
オキサジェン リミテッド |
Crth2アンタゴニスト活性を有する化合物
|
EP2240444A1
(en)
|
2008-01-22 |
2010-10-20 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
JP2011088826A
(ja)
|
2008-01-31 |
2011-05-06 |
Astellas Pharma Inc |
芳香族カルボン酸化合物
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
JP2011526281A
(ja)
|
2008-06-24 |
2011-10-06 |
アミラ ファーマシューティカルズ,インク. |
プロスタグランジンd2受容体のシクロアルカン[b]インドールアンタゴニスト
|
US8124641B2
(en)
|
2008-07-15 |
2012-02-28 |
Hoffmann-La Roche Inc. |
Aminotetrahydroindazoloacetic acids
|
EP2307383B1
(en)
|
2008-07-15 |
2012-05-16 |
F. Hoffmann-La Roche AG |
Aminotetrahydroindazoloacetic acids
|
JP2012502928A
(ja)
|
2008-09-22 |
2012-02-02 |
メルク カナダ インコーポレイテッド |
Crth2受容体アンタゴニストとしてのアザインドール誘導体
|
JP2012502927A
(ja)
|
2008-09-22 |
2012-02-02 |
メルク カナダ インコーポレイテッド |
Crth2受容体拮抗薬としてのインドール誘導体
|
CA2737460C
(en)
|
2008-09-22 |
2016-12-20 |
Merck Frosst Canada Ltd. |
Indole derivatives as crth2 receptor antagonists
|
US20110312945A1
(en)
|
2008-10-01 |
2011-12-22 |
James Jia |
Crth2 modulators
|
GB2465062B
(en)
*
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
WO2010085820A2
(en)
|
2009-01-26 |
2010-07-29 |
Amira Pharmaceuticals, Inc. |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
MY152062A
(en)
|
2009-02-24 |
2014-08-15 |
Merck Sharp & Dohme |
Indole derivatives as crth2 receptor antagonists
|
WO2010142934A1
(en)
|
2009-06-12 |
2010-12-16 |
Pulmagen Therapeutics (Asthma) Limited |
Indole derivatives as ligands of crth2 receptors
|
AU2010272524A1
(en)
|
2009-07-15 |
2012-02-02 |
Merck Serono S.A. |
Tricyclic indole-derived spiro derivatives as CRTH2 modulators
|
WO2011055270A1
(en)
|
2009-11-04 |
2011-05-12 |
Wyeth Llc |
Indole based receptor crth2 antagonists
|
RU2562255C2
(ru)
|
2010-03-22 |
2015-09-10 |
Актелион Фармасьютиклз Лтд |
Производные 3-(гетероариламино)-1,2,3,4-тетрагидро-9н-карбазола и их применение в качестве модуляторов рецепторов простагландина d2
|
US20110311483A1
(en)
|
2010-03-30 |
2011-12-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
WO2012009134A1
(en)
|
2010-07-12 |
2012-01-19 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
KR101928595B1
(ko)
|
2011-04-14 |
2018-12-12 |
이도르시아 파마슈티컬스 리미티드 |
7-(헤테로아릴-아미노)-6,7,8,9-테트라히드로피리도[1,2-a]인돌 아세트산 유도체 및 프로스타글란딘 d2 수용체 조절자로서의 이의 용도
|
CN103450218B
(zh)
|
2012-05-29 |
2015-12-23 |
山东亨利医药科技有限责任公司 |
作为crth2受体拮抗剂的吲哚类三并环衍生物
|
HUE039614T2
(hu)
|
2014-03-17 |
2019-01-28 |
Idorsia Pharmaceuticals Ltd |
Azaindol-ecetsav-származékok és prosztaglandin D2 receptor modulátorokként történõ alkalmazásuk
|
CA2938107A1
(en)
|
2014-03-18 |
2015-09-24 |
Actelion Pharmaceuticals Ltd |
Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
|